Gilead Receives All Required Regulatory Approvals for the Acquisition of Arcellx and Extends Tender Offer
Go back to Gilead Receives All Required Regulatory Approvals for the Acquisition of Arcellx and Extends Tender Offer| Gilead Sciences (NASDAQ: GILD) | Delayed: 125.59 -0.28 (0.22%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $125.87 | 52 Week High | $108.63 | |||
| Open | $126.13 | 52 Week Low | $71.39 | |||
| Day High | $126.51 | P/E | 69.39 | |||
| Day Low | $124.29 | EPS | $1.81 | |||
| Volume | 5,214,637 | |||||
